Changes in serum metabolomics in idiopathic pulmonary fibrosis and effect of approved antifibrotic medication

Overview of attention for article published in Frontiers in Pharmacology, August 2022

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Good Attention Score compared to outputs of the same age and source (78th percentile)

So far, Altmetric has seen 3 X posts from 3 X users, with an upper bound of 6,924 followers.

Metabolomic signatures as biomarkers for disease progression or treatment response in IPF patients? 🫁🧪🔬📈 👉🏻 https://t.co/oGIdbHn5zQ

Changes in serum metabolomics in idiopathic pulmonary fibrosis and effect of approved antifibrotic medication #FrontPharmacol #MassSpec https://t.co/km1upJWbIr

New article: Changes in serum metabolomics in idiopathic pulmonary fibrosis and effect of approved antifibrotic medication https://t.co/LgPytrJ93V #lungcancer #oncology https://t.co/3hGcGd6GOX

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.